{
    "clinical_study": {
        "@rank": "62209", 
        "acronym": "OptiSeDent", 
        "arm_group": [
            {
                "arm_group_label": "Midazolam", 
                "arm_group_type": "Experimental", 
                "description": "Midazolam Mylan 5 mg/ml solution for injection 15mg Oral use Single dose 45 minutes before dental treatment"
            }, 
            {
                "arm_group_label": "Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat", 
                "arm_group_type": "Active Comparator", 
                "description": "Lorazepam Mylan 2,5 mg tabletten 2.5mg Oral use Single dose 45 minutes before dental treatment\nOR\nValium 10 mg/2 ml solution for injection 10mg Intramuscular use Single dose 45 minutes before dental treatment\n+ Akineton 5 mg/ml solution for injection 5mg Intramuscular use Single dose 45 minutes before dental treatment\n+ Dehydrobenzperidol 5 mg/2 ml solution for injection 0,000125 ml/cm2 Intramuscular use Single dose 45 minutes before dental treatment\n+ Atropine sulfate Sterop 0,25mg/1ml solution for injection 0,25mg Intramuscular use Single dose 45 minutes before dental treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The study aims to compare procedural sedation protocols, specifically applied for the\n      delivery of regular dental care in persons with a mental disability.\n\n      The primary objectives are:\n\n        -  To assess the level of cooperation during regular dental care using different\n           procedural sedation protocols\n\n        -  To assess patient safety during regular dental care using different sedation protocols\n\n        -  To assess patient comfort and possible side-effects after regular dental care using\n           different sedation protocols"
        }, 
        "brief_title": "Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Dental Care for Disabled", 
        "condition_browse": {
            "mesh_term": [
                "Mental Disorders", 
                "Mental Retardation"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Minimum age 18yrs\n\n          -  Patient resides at least 6 months in nursing home \"het Gielsbos\".\n\n          -  Patient always gets a sedative protocol to make dental care delivery possible.\n\n          -  Informed consent was obtained from parent/guardian\n\n          -  No medical contra-indication for any of tested sedative protocols\n\n        Exclusion Criteria:\n\n          -  Age under 18yrs\n\n          -  The patient is no resident of the nursing home \"het Gielsbos\" or lives there for less\n             than 6 months.\n\n          -  No need for medicinal support during dental treatment\n\n          -  No informed consent was obtained by parents or the guardian of the patient.\n\n          -  Medical contra-indication for 1 of the sedative protocols"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078336", 
            "org_study_id": "S55859", 
            "secondary_id": "2013-003991-11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Midazolam", 
                "intervention_name": "Midazolam Mylan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat", 
                "intervention_name": "Lorazepam Mylan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat", 
                "intervention_name": "Valium + Akineton + Dehydrobenzperidol + Atropine sulfate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Atropine", 
                "Diazepam", 
                "Midazolam", 
                "Droperidol", 
                "Biperiden", 
                "Lorazepam"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "contact": {
                "email": "dominique.declerck@med.kuleuven.be", 
                "last_name": "Dominique Declerck"
            }, 
            "contact_backup": {
                "email": "ine.opsomer@uzleuven.be", 
                "last_name": "Ine Opsomer"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "zip": "3000"
                }, 
                "name": "Katholieke Universiteit Leuven"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability", 
        "overall_contact": {
            "email": "dominique.declerck@med.kuleuven.be", 
            "last_name": "Dominique Declerck"
        }, 
        "overall_contact_backup": {
            "email": "ine.opsomer@uzleuven.be", 
            "last_name": "Ine Opsomer"
        }, 
        "overall_official": {
            "affiliation": "Katholieke Universiteit Leuven", 
            "last_name": "Dominique Declerck", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Level of cooperation of patient when receiving regular dental care", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the duration of the dental treatment, an expected average of 30 minutes."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078336"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The measure is a composite of\nrecording of blood pressure\nrecording of pulse\nrecording of oxygen saturation", 
                "measure": "Recording of vital parameters during regular dental care delivery", 
                "safety_issue": "No", 
                "time_frame": "24 hrs"
            }, 
            {
                "description": "The measure of patient comfort and possible side-effects after dental treatment session is a composite of\nchanges in appetite\nchanges in toilet behavior\nchanges in level of consciousness\nchanges in level of concentration\nchanges in pattern of epileptic insults\nchanges in mood\nchanges in sleeping pattern\nchanges in level of motor skills", 
                "measure": "Level of patient comfort and possible side-effects after dental treatment session", 
                "safety_issue": "No", 
                "time_frame": "24 hrs"
            }
        ], 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}